June 29, 2020
Those who suffer from the autoimmune disease Myasthenia Gravis (MG) often experience a fragmented journey through their illness because available resources on the disease don’t offer insights beyond clinical information. So to provide an online destination where people with MG can connect with others and access information without feeling defined by their diagnosis, pharmaceutical firm...
read more
